PROCEPT BioRobotics Statistics
Total Valuation
PRCT has a market cap or net worth of $1.59 billion. The enterprise value is $1.37 billion.
Important Dates
The last earnings date was Tuesday, November 4, 2025, after market close.
| Earnings Date | Nov 4, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
PRCT has 55.88 million shares outstanding. The number of shares has increased by 7.15% in one year.
| Current Share Class | 55.88M |
| Shares Outstanding | 55.88M |
| Shares Change (YoY) | +7.15% |
| Shares Change (QoQ) | +0.51% |
| Owned by Insiders (%) | 2.26% |
| Owned by Institutions (%) | 105.33% |
| Float | 53.81M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 5.21 |
| Forward PS | 3.89 |
| PB Ratio | 4.17 |
| P/TBV Ratio | 4.18 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 4.57 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 8.44, with a Debt / Equity ratio of 0.21.
| Current Ratio | 8.44 |
| Quick Ratio | 7.03 |
| Debt / Equity | 0.21 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -25.27 |
Financial Efficiency
Return on equity (ROE) is -27.22% and return on invested capital (ROIC) is -14.77%.
| Return on Equity (ROE) | -27.22% |
| Return on Assets (ROA) | -13.06% |
| Return on Invested Capital (ROIC) | -14.77% |
| Return on Capital Employed (ROCE) | -20.22% |
| Revenue Per Employee | $396,702 |
| Profits Per Employee | -$111,882 |
| Employee Count | 756 |
| Asset Turnover | 0.68 |
| Inventory Turnover | 1.81 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -68.07% in the last 52 weeks. The beta is 0.98, so PRCT's price volatility has been similar to the market average.
| Beta (5Y) | 0.98 |
| 52-Week Price Change | -68.07% |
| 50-Day Moving Average | 34.74 |
| 200-Day Moving Average | 50.32 |
| Relative Strength Index (RSI) | 28.17 |
| Average Volume (20 Days) | 1,655,950 |
Short Selling Information
The latest short interest is 7.61 million, so 13.63% of the outstanding shares have been sold short.
| Short Interest | 7.61M |
| Short Previous Month | 8.15M |
| Short % of Shares Out | 13.63% |
| Short % of Float | 14.15% |
| Short Ratio (days to cover) | 6.56 |
Income Statement
In the last 12 months, PRCT had revenue of $299.91 million and -$84.58 million in losses. Loss per share was -$1.54.
| Revenue | 299.91M |
| Gross Profit | 193.59M |
| Operating Income | -92.53M |
| Pretax Income | -84.58M |
| Net Income | -84.58M |
| EBITDA | -86.39M |
| EBIT | -92.53M |
| Loss Per Share | -$1.54 |
Full Income StatementBalance Sheet
The company has $294.28 million in cash and $78.93 million in debt, giving a net cash position of $215.36 million or $3.85 per share.
| Cash & Cash Equivalents | 294.28M |
| Total Debt | 78.93M |
| Net Cash | 215.36M |
| Net Cash Per Share | $3.85 |
| Equity (Book Value) | 380.28M |
| Book Value Per Share | 6.81 |
| Working Capital | 400.85M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$71.05 million and capital expenditures -$8.68 million, giving a free cash flow of -$79.73 million.
| Operating Cash Flow | -71.05M |
| Capital Expenditures | -8.68M |
| Free Cash Flow | -79.73M |
| FCF Per Share | -$1.43 |
Full Cash Flow StatementMargins
Gross margin is 64.55%, with operating and profit margins of -30.85% and -28.20%.
| Gross Margin | 64.55% |
| Operating Margin | -30.85% |
| Pretax Margin | -28.20% |
| Profit Margin | -28.20% |
| EBITDA Margin | -28.81% |
| EBIT Margin | -30.85% |
| FCF Margin | n/a |
Dividends & Yields
PRCT does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -7.15% |
| Shareholder Yield | -7.15% |
| Earnings Yield | -5.33% |
| FCF Yield | -5.02% |
Dividend DetailsAnalyst Forecast
The average price target for PRCT is $63.50, which is 123.59% higher than the current price. The consensus rating is "Buy".
| Price Target | $63.50 |
| Price Target Difference | 123.59% |
| Analyst Consensus | Buy |
| Analyst Count | 9 |
| Revenue Growth Forecast (5Y) | 26.25% |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
PRCT has an Altman Z-Score of 15.18 and a Piotroski F-Score of 4.
| Altman Z-Score | 15.18 |
| Piotroski F-Score | 4 |
